
1. General Information
PEG GRAFEEL 6 mg Injection is a prescription medicine containing pegfilgrastim, a long-acting granulocyte colony-stimulating factor (G-CSF). It is primarily used to reduce the risk of infection associated with chemotherapy-induced neutropenia in eligible cancer patients.
Pegfilgrastim helps stimulate the bone marrow to produce more neutrophils, a type of white blood cell that plays an important role in fighting infections.
Pegfilgrastim is a biologic medicine, and several biosimilar pegfilgrastim products are also available.
2. Product Information
- Product: PEG GRAFEEL 6 mg Injection
- Active ingredient: Pegfilgrastim
- Strength: 6 mg
- Dosage form: Injection
- Route: Subcutaneous injection
- Drug class: Granulocyte colony-stimulating factor (G-CSF)
- Therapeutic category: Hematopoietic growth factor
- Prescription status: Prescription medicine
FDA records list pegfilgrastim products such as Neulasta and biosimilars in a 6 mg/0.6 mL pre-filled syringe presentation for subcutaneous administration.
3. Uses of PEG GRAFEEL 6 mg Injection
Pegfilgrastim is commonly prescribed to:
- Reduce the risk of infection associated with chemotherapy-induced neutropenia.
- Reduce the likelihood of febrile neutropenia in appropriate patients receiving myelosuppressive chemotherapy.
- Support recovery of neutrophil counts following certain chemotherapy regimens.
- In specific circumstances, pegfilgrastim may also be used following harmful radiation exposure affecting the bone marrow, under specialist medical supervision.
It should be used only for an appropriate medical indication determined by a qualified healthcare professional.
4. Benefits of PEG GRAFEEL 6 mg Injection
Potential clinical benefits include:
- Helps increase the production of neutrophils.
- Helps reduce the duration and severity of chemotherapy-associated neutropenia.
- Can reduce the risk of infection associated with low neutrophil counts.
- Its long-acting formulation can allow convenient dosing around chemotherapy cycles.
- May help patients maintain their planned cancer-treatment schedule when clinically appropriate.
Pegfilgrastim works by stimulating the body's production of neutrophils.
5. Side Effects of PEG GRAFEEL 6 mg Injection
Like all prescription medicines, pegfilgrastim may cause side effects.
Possible adverse effects include:
- Bone pain
- Pain in the arms or legs
- Injection-site reactions
- Headache
- Muscle or joint discomfort
- Fatigue
- Nausea or other gastrointestinal symptoms
Rare but serious reactions can occur, including severe allergic reactions, spleen enlargement or rupture, serious respiratory problems, kidney problems, and certain blood or inflammatory complications.
Seek immediate medical attention for severe abdominal or left shoulder pain, difficulty breathing, facial or throat swelling, severe allergic symptoms, significant reduction in urination, or unusual bleeding/bruising.
6. Common Side Effects
The more commonly reported side effects of pegfilgrastim include:
- Bone pain
- Pain in the arms or legs
- Muscle or joint discomfort
- Headache
- Injection-site discomfort or reaction
- Fatigue
- Nausea
Not every patient experiences these effects, and their severity can vary.
7. How to Use PEG GRAFEEL 6 mg Injection
PEG GRAFEEL should be administered exactly according to the prescribing doctor's instructions.
Pegfilgrastim is generally administered subcutaneously, meaning it is injected under the skin. For chemotherapy-related neutropenia, it is commonly administered as a single dose during each chemotherapy cycle, with the timing determined by the treating physician. It should generally not be administered too soon after chemotherapy.
Important points:
- Do not self-administer unless a healthcare professional has specifically trained you.
- Do not change the dose or injection schedule yourself.
- Do not shake the syringe.
- Check the solution before administration.
- Do not use the medicine if it is expired, cloudy, discolored, or contains unexpected particles.
- Follow the storage instructions provided with the specific product.
The exact administration schedule can vary according to the patient's condition, chemotherapy regimen, and product formulation.
8. How PEG GRAFEEL 6 mg Works
Pegfilgrastim is a long-acting form of granulocyte colony-stimulating factor.
After administration, it stimulates receptors involved in the production and maturation of neutrophils in the bone marrow. This increases the body's neutrophil production and helps restore white blood-cell levels after chemotherapy-associated suppression.
In simple terms:
Chemotherapy → Neutrophil count decreases → Pegfilgrastim stimulates bone marrow → Neutrophil production increases → Infection risk may be reduced.
9. Safety Advice
- Use only under the supervision of a qualified healthcare professional.
- Inform your doctor about any previous allergy to pegfilgrastim, filgrastim, or related medicines.
- Tell your doctor if you have sickle cell disease, as pegfilgrastim treatment may increase the risk of a sickle cell crisis.
- Inform your healthcare provider if you are pregnant, planning pregnancy, or breastfeeding.
- Tell your doctor about all medicines, supplements, and treatments you are receiving.
- Keep all scheduled blood tests and medical appointments.
- Report unexplained fever, breathing difficulties, severe abdominal pain, unusual bruising, or reduced urination promptly.
- Do not share the injection with another person.
- Store and handle the medicine according to the manufacturer's instructions.
Pegfilgrastim reduces the risk of infection associated with neutropenia but does not eliminate the possibility of infection.
10. Frequently Asked Questions (FAQs)
Q1. What is PEG GRAFEEL 6 mg Injection?
PEG GRAFEEL 6 mg Injection is a pegfilgrastim-containing medicine used primarily to support neutrophil recovery and reduce infection risk associated with certain chemotherapy treatments.
Q2. What is the active ingredient?
The active ingredient is pegfilgrastim, assuming the product's packaging confirms this composition.
Q3. What is PEG GRAFEEL 6 mg used for?
It is mainly used to reduce the risk of infection caused by chemotherapy-induced neutropenia in appropriate cancer patients.
Q4. How is PEG GRAFEEL administered?
It is administered by subcutaneous injection, according to the healthcare professional's instructions.
Q5. How often is pegfilgrastim given?
For chemotherapy-associated neutropenia, it is commonly given as a single dose during a chemotherapy cycle, with precise timing determined by the treating physician.
Q6. Does pegfilgrastim prevent every infection?
No. It reduces the risk associated with low neutrophil counts but does not prevent all infections.
Q7. What is the most common side effect?
Bone pain is among the commonly reported side effects of pegfilgrastim.
Q8. Can PEG GRAFEEL be used without a prescription?
No. Pegfilgrastim is a prescription biologic medicine and should be used under appropriate medical supervision.
Q9. Can PEG GRAFEEL be substituted with another medicine?
A suitable alternative may include another pegfilgrastim product or, depending on the clinical situation, a different G-CSF such as filgrastim. Substitution should be decided by the treating healthcare professional.
Q10. Can patients use it during chemotherapy?
Yes, pegfilgrastim is specifically used in appropriate patients receiving certain chemotherapy regimens, but its timing relative to chemotherapy is important and must be determined by the treating physician.
11. Substitute for PEG GRAFEEL 6 mg Injection
Possible alternatives depend on the patient's medical condition, country, product availability, and physician's treatment plan.
Examples of pegfilgrastim products include:
- Neulasta (pegfilgrastim)
- Fulphila (pegfilgrastim-jmdb)
- Ziextenzo (pegfilgrastim-bmez)
- Nyvepria (pegfilgrastim-apgf)
- Udenyca (pegfilgrastim-cbqv)
- Stimufend (pegfilgrastim-fpgk)
- Armlupeg (pegfilgrastim-unne)
These products should not automatically be considered interchangeable solely because they contain pegfilgrastim. Product-specific prescribing information, regulatory status, dose, formulation, and physician guidance should be checked before substitution. FDA's Purple Book lists multiple approved pegfilgrastim products and biosimilars.
Filgrastim is another G-CSF medicine, but it is not simply a direct dose-for-dose substitute for pegfilgrastim; the choice and dosing schedule depend on the clinical situation.
12. Keywords
- PEG GRAFEEL 6 mg Injection
- PEG GRAFEEL Injection
- Pegfilgrastim 6 mg Injection
- Pegfilgrastim Injection exporter
- Pegfilgrastim 6 mg exporter from India
- Pegfilgrastim medicine supplier India
- Pegfilgrastim injection supplier
- Pegfilgrastim injection manufacturer
- Pegfilgrastim 6 mg/0.6 mL
- G-CSF injection supplier
- Granulocyte colony-stimulating factor injection
- Neutropenia treatment injection
- Chemotherapy-induced neutropenia medicine
- Febrile neutropenia prevention
- Oncology supportive care medicine
- Cancer supportive care injection
- Pegfilgrastim exporter from Nagpur India
- PEG GRAFEEL supplier India
- PEG GRAFEEL 6 mg exporter
- Pegfilgrastim pharmaceutical exporter
- Pegfilgrastim exporter to USA
- Pegfilgrastim exporter to UK
- Pegfilgrastim exporter to Australia
- Pegfilgrastim exporter to Singapore
- Pegfilgrastim exporter to Canada
- Pegfilgrastim exporter to South Korea
- Pegfilgrastim exporter to UAE
- Pharmaceutical exporter from Nagpur India
- Oncology medicine exporter India
- Injectable oncology medicines supplier
- Genuine pegfilgrastim medicine supplier
Keywords







